Literature DB >> 10193765

Prostanoid receptors involved in the relaxation of human pulmonary vessels.

L Walch1, C Labat, J P Gascard, V de Montpreville, C Brink, X Norel.   

Abstract

1. To characterize the prostanoid receptors on human pulmonary smooth muscle involved in vasodilatations, isolated arteries and veins were contracted with norepinephrine (10 microM) and vessels were subsequently challenged with different prostanoid-receptor agonists in the absence or presence of selective antagonists. 2. Prostaglandin D2 (PGD2) and the selective DP-receptor agonist, BW245C, induced relaxations in the contracted human pulmonary venous preparations. The pD2 values were: 6.88+/-0.11 (n=17) and 7.31+/-0.12 (n=5), respectively. The relaxant responses induced by PGD2 were reduced by the selective DP-receptor antagonist, BWA868C, and the estimated pA2 value was 7.84+/-0.16 (n=4). PGD2 and BW245C did not relax contracted human pulmonary arteries. 3. The selective IP-receptor agonists, iloprost and cicaprost, both induced relaxations in the contracted human vascular preparations. The pD2 values for iloprost were: 7.84+/-0.08 (n=6) and 8.25+/-0.06 (n=4) and for cicaprost: 8.06+/-0.12 (n=5) and 8.11+/-0.09 (n=5) in arteries and veins respectively. 4. Prostaglandin E2 (PGE2) and the EP2/EP3-receptor agonist, misoprostol, partially relaxed the contracted venous preparations and the pD2 values were: 8.10+/-0.15 (n=15) and 6.24+/-0.33 (n=3), respectively. These relaxations suggest the presence of an EP receptor in the human pulmonary veins. The contracted human pulmonary arteries did not relax when challenged with PGE2. 5. In human pulmonary venous preparations, the PGE2-induced relaxations were neither modified by treatment with TP/EP4-receptor antagonist, AH23848B (10 and 30 microM, n=6), nor by the DP/EP1/EP2-receptor antagonist, AH6809 (3 microM, n=6). 6. These data suggest that the relaxation induced by prostanoids involved DP-, IP-receptors and to a lesser extent an EP-receptor on human pulmonary venous smooth muscle. In contrast, only the IP-receptor is involved in the prostanoid induced relaxations on human pulmonary arterial smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10193765      PMCID: PMC1571232          DOI: 10.1038/sj.bjp.0702393

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

Review 1.  International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.

Authors:  R A Coleman; W L Smith; S Narumiya
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

2.  Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.

Authors:  J W Regan; T J Bailey; D J Pepperl; K L Pierce; A M Bogardus; J E Donello; C E Fairbairn; K M Kedzie; D F Woodward; D W Gil
Journal:  Mol Pharmacol       Date:  1994-08       Impact factor: 4.436

3.  Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.

Authors:  S J Lydford; K McKechnie
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

4.  Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2.

Authors:  S An; J Yang; M Xia; E J Goetzl
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

5.  Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system.

Authors:  O Nakagawa; I Tanaka; T Usui; M Harada; Y Sasaki; H Itoh; T Yoshimasa; T Namba; S Narumiya; K Nakao
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

6.  Prostaglandin receptors coupled to adenylyl cyclase in the iris-ciliary body of rabbits, cats and cows.

Authors:  P Bhattacherjee; L Rhodes; C A Paterson
Journal:  Exp Eye Res       Date:  1993-03       Impact factor: 3.467

7.  Endothelium dependence of prostanoid-induced relaxation in human hand veins.

Authors:  M Arner; T Uski; E D Högestätt
Journal:  Acta Physiol Scand       Date:  1994-03

8.  A novel inhibitory prostanoid receptor in piglet saphenous vein.

Authors:  R A Coleman; S P Grix; S A Head; J B Louttit; A Mallett; R L Sheldrick
Journal:  Prostaglandins       Date:  1994-02

9.  Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.

Authors:  Y M Qian; R L Jones; K M Chan; A I Stock; J K Ho
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

10.  Cloning and expression of a cDNA for the human prostanoid IP receptor.

Authors:  Y Boie; T H Rushmore; A Darmon-Goodwin; R Grygorczyk; D M Slipetz; K M Metters; M Abramovitz
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

View more
  26 in total

1.  Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.

Authors:  Laurence Walch; Xavier Norel; Magnus Bäck; Jean-Pierre Gascard; Sven-Erik Dahlén; Charles Brink
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice.

Authors:  Abdullah Shafique Ahmad; Muzamil Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Age (Dordr)       Date:  2010-03-05

Review 3.  Mechanisms of drug combinations: interaction and network perspectives.

Authors:  Jia Jia; Feng Zhu; Xiaohua Ma; Zhiwei Cao; Zhiwei W Cao; Yixue Li; Yixue X Li; Yu Zong Chen
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

4.  Apolipoprotein E favours the blunting by high-fat diet of prostacyclin receptor activation in the mouse aorta.

Authors:  Yanhua Cheng; Paul M Vanhoutte; Susan W S Leung
Journal:  Br J Pharmacol       Date:  2018-07-22       Impact factor: 8.739

5.  Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles.

Authors:  L J Janssen; M Premji; S Netherton; J Coruzzi; H Lu-Chao; P G Cox
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.

Authors:  L Walch; V de Montpreville; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

7.  Preoperative Intubation and Lack of Enteral Nutrition are Associated with Prolonged Stay After Arterial Switch Operation.

Authors:  Ilias Iliopoulos; Redmond Burke; Robert Hannan; Juan Bolivar; David S Cooper; Farhan Zafar; Anthony Rossi
Journal:  Pediatr Cardiol       Date:  2016-04-15       Impact factor: 1.655

8.  Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1.

Authors:  Katherine E Wiley; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

Review 9.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

10.  Prostaglandin E2 after septostomy for simple transposition.

Authors:  Lynne Mary Beattie; Karen A McLeod
Journal:  Pediatr Cardiol       Date:  2008-12-16       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.